Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

URN to cite this document:: urn:nbn:de:bvb:355-epub-555443
DOI to cite this document:: 10.5283/epub.55544

Leininger, Simon B. ; Staudner, Stephan T. ; Vogel, Manuel J. ; Mustroph, Julian

; Hubauer, Ute ; Wallner, Stefan

; Lehn, Petra ; Burkhardt, Ralph

; Meindl, Christine

; Hanses, Frank

; Zimmermann, Markus ; Maier, Lars S.

; Hupf, Julian

; Jungbauer, Carsten G.

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 13 Feb 2024 08:51

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background The aim of this study was to investigate whether bioactive adrenomedullin (bio-ADM) and interleukin-6 (IL-6) are related to acute kidney injury (AKI) and severe illness in COVID-19 patients. Methods 153 patients with COVID-19 admitted to the emergency department (ED) were included. Blood samples were collected from each patient at admission. Bio-ADM and IL-6, as well as DPP3 and ...